Sulzberger Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sulzberger Capital Advisors's LLY Position: Q3 2026 in Review
Sulzberger Capital Advisors increased its Eli Lilly (LLY) stake by 31% in Q3 2026, buying an estimated $330K and bringing the position to 1,187 shares worth $1.37M. The position accounts for 1.37% of the portfolio, ranked #22.
Sulzberger Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Sulzberger Capital Advisors held 1,187 shares of Eli Lilly worth $1.37M as of Q3 2026.
- Sulzberger Capital Advisors bought 280 Eli Lilly shares in Q3 2026, an estimated $330K.
- Eli Lilly made up 1.37% of Sulzberger Capital Advisors's portfolio in Q3 2026, its #22 holding.
- Sulzberger Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Sulzberger Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.